Table 2.

Distribution of hypertension and diabetes among population in rural Sudan

Hypertension and Diabetes Status		States▲
		River Nile	Gadarif	Northern	Gazera	Total	P-value **
¥ ᶋMeasured Blood Pressure	Hypertension ≥140/≥90	15.3%	17.9%	16.4%	14.4%	15.8%	P-value > 0.05
ᾤ Known hypertensive population		19.9%	17.3%	19.3%	23.3%	20.1%	P-value <0.05
Hypertension among Known hypertensive individuals		75.6%	72.1%	66.2%	72.3%	71.7%	P-value >0.05
*TOD among known hypertensive		5.8%	4.1%	5.3%	7.2%	22.4%	P-value >0.05
ᵿDiabetic population		12.6%	9.2%	10.119%	10.4%	10.6%	P-value> 0.05
Hypertension among diabetic population		50.5%	54.2%	61.6%	51.1%	53.9%	P-value > 0.05
Both diabetic and known hypertensive		4.3%	3.0%	2.8%	3.2%	3.3%	P-value >0.05
Hypertension among Both diabetic and known hypertensive		85.3%	73.7%	75.0%	82.1%	80.2%	P-value >0.05
Individuals on antihypertensive medications		74.8%	78.2%	76.3%	76.7%	76.4%	P-value > 0.05
Hypertension among individuals on anti-hypertensive medication		54.3%	50.0%	41.5%	37.4%	44.9%	P-value < 0.05

^¥Overall mean systolic BP 128.6±17.7 and mean diastolic BP 81.5±11.6. Mean blood pressure in females and males was 127.9/80.6 versus 129.6/82.9 respectively (P-value <0.05). Mean systolic and diastolic blood pressure among hypertensive individuals was 154.74 ±14.4 and 97.98± 8.4 respectively

^ᶋANOVA test: mean systolic blood pressure among male and females on anti-hypertension medication is 144.93±16.5 versus 146.09±21.1 respectively (P- value > 0.05) and mean diastolic blood pressure is 91.60±11.4 versus 88.87±12.2 respectively (P-value < 0.05)

^ᾤMean duration of hypertension is 6.63±6.86

^ᵿMean duration of diabetes is 7.9±7.89

^*(TOD): target organs damage defined as complications regarding central nervous system, renal and cardiovascular

^**P value at 95% confidence level using Chi square test

^▲Percent calculated from sample sizes in states.